ELEANOR HALEY-CIULLA: Open Payments
NPI 1326014093 · READING, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$331 in 17 payments from 8 companies in 2025. Trend: 2023 $144 · 2024 $381 · 2025 $331
Food & beverage: $331
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 5 | $115 |
| ViiV Healthcare Company | 3 | $45 |
| Janssen Biotech, Inc. | 2 | $44 |
| QOL Medical, LLC | 2 | $43 |
| ABBVIE INC. | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Gilead Sciences, Inc. | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $4 |
Products named: REZDIFFRA, APRETUDE, TREMFYA, Sucraid, RINVOQ, ENTYVIO, SKYRIZI, VOQUEZNA.
Industry payments across MA — which companies pay providers there.
